शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
AKUMSNSEAkums Drugs and Pharmaceuticals Limited· Pharmaceuticals & BiotechnologyHighNeutral
Announced Thu, 13 Nov, 2025 · 16:45 IST

Q2 FY26 results with USD 24M Africa investment and Income Tax notice update

Emphasis of matterResults View source PDFExplain this filing

AKUMS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-2.9%Reaction day
₹439.00
prior close
₹430.00
announcement price
After-mkt
timing
Nifty Microcap 250market · index membership as recorded later (tracked since Jun 2026)-0.1%-2.8% vs market
Pharmaceuticals peers, median of 157sector+0.0%-2.9% vs sector

On the reaction day the stock moved 2.8 pts less than Nifty Microcap 250 and 2.9 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-2.3
10m
-2.5
15m
-3.5
30m
-2.8
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-2.9-0.1-2.8+0.0-2.9
Next day
+0.2+0.5-0.3-0.1+0.4
2d
-2.0-0.3-1.7-0.9-1.2
3d
-3.2-0.5-2.7-1.3-1.8
4d
-4.0-0.8-3.2-1.6-2.4
5d
-3.6-2.3-1.3-2.3-1.4
1w
-3.6-2.8-0.8-2.9-0.7
15d
-4.4-4.9+0.4-3.1-1.4
1m
-3.8-4.7+0.9-4.4+0.5
2m
+1.2-7.7+8.9-5.7+6.9
3m
+8.7-7.8+16.5-10.7+19.4
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 157Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Akums reported Q2 and H1 FY26 results. Consolidated revenue was flat at Rs 2,041 crore while profit after tax fell 16 percent to Rs 107 crore. Standalone PAT dropped 26 percent. Board approved a USD 24 million (Rs 200 crore) staggered investment in a new Zambia subsidiary for African manufacturing. Auditors flagged as Emphasis of Matter an Income Tax search from January 2025 - a Section 158BC notice has been received with returns being filed. Report has no qualifications.

Likely market impact

Soft profits but USD 24M Africa expansion plan underway; unresolved Income Tax matter remains a key risk.